Growth and sustainability of MedTech SMEs

Promoting the growth and sustainability of small and medium sized businesses (SMEs) has long been a UK government priority with a compelling policy story: alongside recognisable corporate giants in the life sciences and MedTech sectors, the UK will be wanting to continue to support the vibrant ecosystem of entrepreneurialism with a wide range of SMEs contributing to the R&D value chain. With the end of the Brexit transition period and the government’s levelling-up agenda, policymakers want value and innovation to increase in the UK but also to remain here. This is reflected in the government’s commitment to continue investing in R&D.

To discuss the UK’s SME landscape, current policy challenges facing SMEs, and ongoing opportunities facing these companies, Global Counsel hosted a panel event with Lord Bethell, UK Minister for Innovation, Professor Lord Darzi, Chair of the Institute of Global Health Innovation at Imperial College London, Per Vegard Nerseth, CEO at CMR Surgical, Claire Biot, VP for Life Sciences at Dassault Systèmes and Graeme Tunbridge, Interim Director of Devices at MHRA. The discussion was chaired by GC adviser Dr Harpreet Sood.